リネゾリド関連低ナトリウム症のリスク要因:高齢患者の選択的予測因子として血清アルブミンの減少
Liang Liang1, Bo-Lin Zhu1, Di Chen1
1Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application, (Beijing Hospital), Beijing, China.
Annals of medicine
|August 31, 2025
まとめ
常見の副作用であるラインゾリド誘発性低ナトリウム症は,心血管疾患と治療期間に関連しています. 治療中の血清アルブミンのモニタリングは,特に高齢者の早期発見に不可欠です.
科学分野:
- 薬理学について
- 臨床医学
- 腎臓科
背景:
- ラインゾリドは,実際の症例の約20%で低ナトリウム症に関連しています.
- リネゾリド誘発性低ナトリウム血症に関する研究は限られており,症例報告は少ない.
- この研究では,高齢者に焦点を当てて,ラインゾリド誘発性低ナトリウム血症の危険因子を調査しています.
研究 の 目的:
- ラインゾリド誘発性低ナトリウム血症のリスク要因を特定する.
- 65歳以上の患者の特定の危険因子を調査する.
- ラインゾリド治療中の血清アルブミン濃度のモニタリングの臨床的意義を決定する.
主な方法:
- 2018年1月から2023年12月までの遡及研究
- ラインゾリドを少なくとも3日間投与した18歳以上の患者も含む.
- リスク因子の特定のためにバイナリロジスティック回帰分析とサブグループ分析を使用した.
主要な成果:
- 心血管疾患の病歴,推定グルメルフィルタレーション率,ラインゾリドの投与期間が低ナトリウム血症の危険因子として特定されました.
- 65歳以上の患者では,治療期間,心血管疾患,内分泌疾患,および血清アルブミン (ALB) の低下が主要な指標であった.
- 治療中のALB値の低下は,ベースラインのALB値よりも,低ナトリウム血症のより具体的な予測因子です.
結論:
- リネゾリド誘発性低ナトリウム症は有害な結果と関連しています.
- 血清ナトリウムとALBのレベルをモニタリングすることは,ラインゾリドを服用している患者にとって不可欠です.
- ラインゾリド治療中の血清アルブミンの低下は,低ナトリウム血症の有意な予測因子である.
さらに関連する動画
関連する概念動画
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
751
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
751
01:24Hemodialysis II: Procedure and Complications
128
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
128
01:22Acute Kidney Injury VI: Nursing Management
57
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
57
01:24Nephrotic Syndrome I : Introduction
27
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
27
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
112
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
112
01:24Nephrotic Syndrome III : Nursing Management
44
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
44